QSAM Biosciences, Inc.

$8.30-99.95%($-16591.70)
TickerSpark Score
46/100
Weak
40
Valuation
20
Profitability
60
Growth
80
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QSAM research report →

52-Week Range0% of range
Low $4.10
Current $8.30
High $16600.00

Companyqsambio.com

QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical.

CEO
Douglas R. Baum
IPO
2012
Employees
4
HQ
Austin, TX, US

Price Chart

+40.68% · this period
$8.30$6.23$4.15May 03Nov 01May 02

Valuation

Market Cap
$18.44K
P/E
-6.67
P/S
0.00
P/B
43.58
EV/EBITDA
-0.00
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
1617.91%
ROIC
-579.91%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-4,393,126 · 27.68%
EPS
$-1.24 · 64.06%
Op Income
$-3,942,510
FCF YoY
-5.02%

Performance & Tape

52W High
$16600.00
52W Low
$4.10
50D MA
$649.00
200D MA
$166.26
Beta
1.81
Avg Volume
6.09K

Get TickerSpark's AI analysis on QSAM

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 2, 24Piazza C Richardsell188
May 2, 24Baum Douglas Rsell188
May 2, 24Link Jr. Charles Jsell41
May 2, 24Nelson Christopher M.sell91
May 2, 24Sax Adriannsell5
May 2, 24King Adamsell11
Jan 15, 23Checkmate Strategic Capital 2, LLCother50,000
Dec 19, 23Checkmate Strategic Capital 2, LLCother50,000
Feb 6, 24Checkmate Strategic Capital 2, LLCother156
Feb 6, 24Baum Douglas Rother1,302

Our QSAM Coverage

We haven't published any research on QSAM yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate QSAM Report →

Similar Companies